Originally presented at a dinner event at ARVO 2020 entitled: "Meaningful Clinical Endpoints with ERG: Why Detecting Functional Change before Structural Change Matters"
The talk centered on the handheld and non-mydriatic RETeval Device for ERG testing that is rapid, non-invasive, and ideal for various endpoint tracking for pharmaceutical or clinical research in the ocular space.
Dr. Mitch Brigell, PhD presented on practical electroretinographic testing with the RETeval as both a clinical efficacy and a translational biomarker. It provides, for example, a functional measure of diabetic retinopathy risk progression that was more predictive than structural imaging. Likewise, functional testing of the ganglion cell layer (PhNR) provides an objecting measure of glaucoma.
Dr. Quentin Davis, PhD, presented on the scientific and logistical rationale for conducting clinical trials with ERG testing using the RETeval Device. The reliability and relatively inexpensive cost of the unit, combined with it's rapid and non-invasive interface makes it ideal for efficacy endpoint tracking in clinical trials related to ocular disease.
Learn more at lkc.com
Mitch Brigell, PhD
00:00-Intro
00:40-RETeval: Practical ERG Technology for Clinical Trials
2:51-Prognostic Value of ERG in Diabetic Retinopathy
12:36-Exploratory Endpoints: Phase 2B Study in NPDR patients
18:54-ERG Photopic Negative Response (PhNR) for Ganglion Cell Activity (e.g. Glaucoma)
22:54-Safety: The FDA's Viewpoint on Electroretinography
30:45-Translational ERG Testing in Preclinical Models
33:50-Preclinical ERG Use in Safety: Pharmacology and Toxicology
34:58-Mitch Brigell, PhD: Summary
Quentin Davis, PhD
35:44-Scientific Rationale for why the RETeval Device is the essential ERG device for clinical studies
40:58-Logistical rationale for deploying the RETeval Device in clinical studies
41:53-Video demo of the RETeval Device in action
43:51-The RETeval Device ensures quality results
47:21-Post-test quality checks (with examples)
54:01-Quentin Davis, PhD: Summary
Негізгі бет Ғылым және технология Meaningful Clinical Endpoints with Electroretinography
Пікірлер